Career Opportunities

OUR Organization

VISION

Our vision at Prostate Cancer Canada (PCC) is to become the global leader in the fight against prostate cancer, earning the enthusiasm and support of Canadians through integrity, compassion, and innovation.

MISSION

Prostate Cancer Canada raises funds for the development of programs related to awareness, public education, advocacy, support of those affected, and research into the prevention, detection, treatment and cure of prostate cancer.

DID YOU KNOW?

  • We act as the primary support resource for men diagnosed with the disease, and for their families.

  • We are the only national foundation dedicated to the elimination of this disease through research, education, support and awareness.

  • Our logo is a symbol of hope – that we know we will achieve the goal of eliminating prostate cancer, and a symbol of unity – that we can only achieve this when working together.

All positions are based in Toronto Head Office unless otherwise specified.
 


 


Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive